MIR1-1HG: A Potential Drug Target Or Biomarker (G128826)
MIR1-1HG: A Potential Drug Target Or Biomarker
MIR1-1HG, also known as C20orf166, is a protein that is expressed in various tissues and cells throughout the body. It is a member of the IMP family, which includes proteins that play a critical role in the intracellular signaling pathway known as the insulin-like growth factor (IGF) pathway.
The IGF pathway is a well-established signaling pathway that is involved in cell growth, differentiation, and survival. It is a critical pathway for the development and maintenance of tissues and organs, and is often dysregulated in various diseases, including cancer.
MIR1-1HG is of particular interest as a potential drug target or biomarker because of its involvement in the IGF pathway. It has been shown to play a role in the regulation of cell proliferation, differentiation, and survival, and has been implicated in the development and progression of various diseases, including cancer.
One of the key functions of MIR1-1HG is its role in the regulation of the IGF pathway. It is a key regulator of the insulin receptor, which is a critical protein that plays a central role in the IGF pathway. The insulin receptor is composed of two distinct subunits, alpha and beta, and MIR1-1HG is known to interact with both subunits to regulate their activity.
MIR1-1HG has been shown to play a critical role in the regulation of cell proliferation and survival. It has been shown to promote the growth and survival of various cell types, including cancer cells. For example, studies have shown that MIR1-1HG promotes the growth of human cancer cells in a variety of models, including in vitro and in vivo models.
MIR1-1HG has also been shown to contribute to the development and progression of various diseases, including cancer. For example, studies have shown that MIR1-1HG is overexpressed in various cancer types, including breast, ovarian, and prostate cancers. This overexpression is associated with a variety of negative outcomes, including increased cancer cell proliferation and the development of cancer stem cells.
In addition to its role in the IGF pathway, MIR1-1HG is also involved in the regulation of various other signaling pathways. For example, it is known to play a role in the regulation of cell adhesion, and has been shown to contribute to the development and progression of various diseases, including cancer.
MIR1-1HG is also of interest as a potential biomarker because of its expression in various tissues and cells. This makes it a potential target for diagnostic tests and therapies. For example, studies have shown that MIR1-1HG is expressed in a variety of tissues and cells, including cancer cells, and may be a useful biomarker for the diagnosis and treatment of various diseases.
In conclusion, MIR1-1HG is a protein that is of particular interest as a potential drug target or biomarker due to its involvement in the IGF pathway and its role in the regulation of cell proliferation and survival. Its potential as a drug target or biomarker is further supported by its involvement in the regulation of various other signaling pathways and its expression in a variety of tissues and cells. Further research is needed to fully understand the role of MIR1-1HG in the IGF pathway and its potential as a drug target or biomarker.
Protein Name: MIR1-1 Host Gene
The "MIR1-1HG Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1-1HG comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1-2 | MIR100 | MIR100HG | MIR101-1 | MIR101-2 | MIR10394 | MIR10396B | MIR10399 | MIR103A1 | MIR103A2 | MIR103B1 | MIR103B2 | MIR105-1 | MIR105-2 | MIR10527 | MIR106A | MIR106B | MIR107 | MIR10A | MIR10B | MIR11181 | MIR11400 | MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266
